Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyclopropanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101585767B reveals a high-yield synthesis for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropionate, eliminating meta-isomers and reducing environmental impact for reliable supply.
Patent CN101585768B details a high-yield route for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropanoate. Eliminates meta-isomers for superior supply chain reliability.
Patent CN109305983B reveals a novel ethylene-based route for cyclopropylboronic acid, eliminating hazardous cyclopropyl bromide and offering significant supply chain stability.
Novel enzymatic and cobalt-catalyzed route for antiviral intermediate. Reduces toxicity, improves safety, ensures reliable supply chain for pharmaceutical manufacturing.
Patent CN103664471A reveals a novel one-step synthesis of 1-cyclopropylnaphthalene from 1-vinylnaphthalene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN104193645A reveals efficient asymmetric synthesis. Delivers >99.5% ee. Ideal for Cilastatin production. Cost-effective supply chain solution for global buyers.
Patent CN1384105A details a robust asymmetric copper complex for cyclopropanation, offering significant cost reduction in agrochemical intermediate manufacturing and enhanced supply chain reliability.
Novel method for (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate. High yield, mild conditions, scalable process for antiviral drugs.
Patent CN111205176B reveals a green synthesis route for 3,5-dihalogen-2-pentanone using acetoacetate, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN101343306B reveals a low-cost synthesis for 6,7-methylene steroids using dibromomethane, offering significant supply chain advantages for Drospirenone manufacturers.
Patent CN101343306B reveals a low-cost synthesis for 6,7-methylene steroids using dibromomethane. Ideal for Drospirenone intermediates with reduced production costs.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Advanced asymmetric copper complex technology for high-purity cyclopropane carboxylates. Enables cost reduction in pharmaceutical intermediates manufacturing and agrochemical production.
Patent CN1798609A reveals a novel copper catalyst system enabling high-yield, low-temperature synthesis of optically active cyclopropane compounds for pyrethroid production.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Patent CN103687489A reveals a safer, scalable route for 5-azaspiro[2.4]heptane-6-carboxylic acid, eliminating pyrophoric reagents for reliable HCV inhibitor supply.
Patent CN1774430A details a novel sulfolane-based cyclopropanation for taxane intermediates, offering improved purity and scalable manufacturing for API production.
Patent CN114456101A reveals a streamlined 3-step synthesis for PF-07321332 key intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102070575B reveals a safer, three-step synthesis of Caronic Anhydride from methyl isobutenyl ketone, offering significant cost reduction in API manufacturing.